Xenetic Biosciences, Inc. quarterly report, Q3 FY2012

Filing identity and business context

Important filing mismatch: The supplied filing is for General Aircraft, Inc., not Xenetic Biosciences, Inc. It reports the quarter ended May 31, 2012, rather than identifying itself as a Xenetic 2012 Q3 filing. The company describes itself as a development-stage helicopter rental business operating in the Las Vegas area, with one Robinson R44 helicopter managed by Elite Aviation VGT, LLC, a related party. The filing’s fiscal year ends August 31.

Financial results and position

  • Revenue: $36,430 for the three months and $86,146 for the nine months ended May 31, 2012. The filing provides no prior-year comparable operating period.
  • Profit and expenses: Three-month operating expenses were $72,056 and operating loss was $35,626; interest expense was $3,232 and net loss was $38,858. Nine-month operating expenses were $162,657 and operating loss was $76,511; interest expense was $9,780 and net loss was $86,291. Net loss since inception was $94,526.
  • Margins: No gross-margin measure is reported. Operating and net losses exceeded revenue in both reported periods.
  • Cash flow: Nine-month cash used in operations was $11,944; there were no investing cash flows during that period. Financing provided $35,000 from the April stock offering. Cash increased from $10,000 at August 31, 2011 to $33,056 at May 31, 2012. No cash interest or taxes were reported as paid.
  • Liquidity: Current assets were $105,524, including $33,056 cash and $72,468 accounts receivable. Current liabilities were $140,569, giving a $35,045 working-capital deficit.
  • Debt: Long-term debt was $212,813, secured by company assets and bearing 6% interest. Semiannual interest-only payments are required; principal and accrued interest are due at maturity on August 11, 2016. Accrued interest at May 31 was $10,328.
  • Other balance-sheet items: Total assets were $303,856, including net fixed assets of $198,332. Stockholders’ deficit was $49,526. Shares outstanding were 13.5 million at May 31, up from 10 million at August 31, 2011; the filing reports 13.5 million outstanding on July 10, 2012.

Changes, outlook, and risks

  • The company raised $35,000 by selling 3.5 million common shares at $0.01 per share in April 2012. Accounts receivable increased to $72,468, and accounts payable and accrued expenses increased to $130,241 from $7,374 at August 31, 2011.
  • Management estimated about 500 rental hours annually and an average rental rate of approximately $370 per hour. These are estimates, not assurances. The filing gives estimated gross profit after management fees of $33.10 per rental hour, before other stated operating costs.
  • A helicopter overhaul is expected at 2,200 lifetime hours and estimated to cost approximately $170,000. Management anticipated needing additional financing for roughly $100,000 of that cost after reserving an estimated $70,000; the timing and availability of financing are uncertain.
  • The company reported substantial doubt about its ability to continue as a going concern, citing operating losses, negative working capital, limited cash reserves, reliance on one aircraft, and dependence on future financing or profitable operations. Management said it did not expect to seek additional financing during the remainder of the fiscal year, despite describing financing as necessary to its longer-term plans.
  • Risks include uncertain rental demand, fuel-price fluctuations, unexpected aircraft repairs, competition, and inability to raise capital. The aircraft-use and management agreement with Elite is month-to-month, requires 90 days’ notice to terminate, and includes a 60-day post-termination non-compete covenant. Elite is affiliated with the company’s former officers, and the current sole officer is an Elite employee.
  • Disclosure controls were described as ineffective due mainly to limited staffing, inadequate segregation of duties, and control procedures not being regularly performed. A later passage in the same controls discussion calls the controls effective at a reasonable-assurance level, creating an internal inconsistency.
  • The filing says there were no pending legal proceedings or off-balance-sheet arrangements. It gives no formal financial guidance.

Most important facts to verify

  1. Confirm that this is the intended filing: the document identifies General Aircraft, Inc., not Xenetic Biosciences, Inc.
  2. Reconcile the filing’s inconsistent statements about disclosure-control effectiveness and its statement that the company had not received revenues, which conflicts with reported rental revenue.
  3. Assess collectability and timing of the $72,468 receivable and settlement of $130,241 in accounts payable and accrued expenses.
  4. Verify aircraft utilization, rental economics, related-party charges and oversight, and the funding plan for the future overhaul.
  5. Evaluate going-concern financing needs and the terms and maturity obligations of the secured aircraft loan.